Allergan
Allergan[edit]
Allergan plc is a global pharmaceutical company specializing in aesthetics, eye care, neurosciences, and gastrointestinal treatments.
Overview[edit]
Founded as a small eye care company, Allergan has since grown into a multifaceted pharmaceutical giant, known especially for its product Botox.
History[edit]
- 1948: Allergan was founded by Gavin S. Herbert to produce nose drops and an anti-allergy medication in Los Angeles.
- 1950s: The company expanded into eye care products, launching its first blockbuster drug, an eye drop.
- 1980s-1990s: Allergan expanded globally, establishing its presence in over 100 countries.
- 2015: Allergan was acquired by Actavis plc, which then adopted the name Allergan.
- 2020: AbbVie acquired Allergan in a deal worth approximately $63 billion.
Notable Products[edit]
- Botox (onabotulinumtoxinA): A neurotoxin used for various cosmetic and therapeutic treatments.
- Restasis: A medication used to increase tear production in people with dry eyes.
- Juvederm: A range of injectable dermal fillers.
- CoolSculpting: A non-surgical body contouring treatment.
Research and Development[edit]
Allergan has been at the forefront of R&D in its specialized fields, with a focus on patient-centric innovation. Its R&D centers globally collaborate on drug discovery and development.
Corporate Social Responsibility[edit]
Allergan has committed itself to sustainability, patient welfare, and community service. Their initiatives include patient assistance programs, donations, and environmental sustainability practices.
Controversies[edit]
Allergan has faced its share of controversies, especially related to drug pricing, patents, and FDA regulations.
Facilities[edit]
With its global presence, Allergan has R&D, manufacturing, and commercial operations located in various regions around the world.
See Also[edit]
References[edit]
- [1] "Allergan: Our History". Allergan Official Website.
- [2] "The Evolution of Allergan". Pharmaceutical Executive Magazine.
- [3] "AbbVie Completes Acquisition of Allergan". Reuters.
